Cargando…
The Effect of Vector Silencing during Picornavirus Vaccination against Experimental Melanoma and Glioma
Virus vector-based vaccination against tumor-specific antigens remains a promising therapeutic approach to overcome the immune suppressive tumor microenvironment. However, the extent that the desired CD8 T cell response against the targeted tumor antigen is impacted by the CD8 T cell response agains...
Autores principales: | Malo, Courtney S., Renner, Danielle N., Huseby Kelcher, April M., Jin, Fang, Hansen, Michael J., Pavelko, Kevin D., Johnson, Aaron J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999064/ https://www.ncbi.nlm.nih.gov/pubmed/27560502 http://dx.doi.org/10.1371/journal.pone.0162064 |
Ejemplares similares
-
An Elite Controller of Picornavirus Infection Targets an Epitope That Is Resistant to Immune Escape
por: Bell, Michael P., et al.
Publicado: (2014) -
Immunomodulation Mediated by Anti-angiogenic Therapy Improves CD8 T Cell Immunity Against Experimental Glioma
por: Malo, Courtney S., et al.
Publicado: (2018) -
Effective Treatment of Established GL261 Murine Gliomas through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+ T Cell Responses
por: Renner, Danielle N., et al.
Publicado: (2015) -
Mechanisms of interleukin 4 mediated increase in efficacy of vaccines against opioid use disorders
por: Crouse, Bethany, et al.
Publicado: (2020) -
Non-equivalent antigen presenting capabilities of dendritic cells and macrophages in generating brain-infiltrating CD8(+) T cell responses
por: Malo, Courtney S., et al.
Publicado: (2018)